Immunogenetic correlates of neisseria gonorrhoeae infection in adolescents

Sexually Transmitted Diseases

Volumn 35, Issue 7, 2008, Pages 656-661

  Geisler, William M ^a,b   Wang, Chengbin ^b   Tang, Jianming ^a   Wilson, Craig M ^a,c   Crowley Nowick, Peggy A ^d   Kaslow, Richard A ^a,b,c  

^a Departments of Medicine   (United States)

^b Departments of Microbiology and Epidemiology   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Berlex Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; CYTOKINE; HLA ANTIGEN;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; CYTOKINE PRODUCTION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENITAL SYSTEM; GONORRHEA; HAPLOTYPE; HUMAN; IMMUNOGENETICS; INNATE IMMUNITY; INTRON; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; PATHOGENESIS; PROMOTER REGION; BLOOD; CHILD HEALTH CARE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LONGITUDINAL STUDY; METABOLISM; MONONUCLEAR CELL; NEGRO; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS; UNITED STATES;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; AFRICAN CONTINENTAL ANCESTRY GROUP; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GONORRHEA; HLA ANTIGENS; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALE; NEISSERIA GONORRHOEAE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; UNITED STATES;

EID: 50649125294     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31816b6593     Document Type: Article

References (42)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2004. Atlanta, GA: U.S. Department of Health and Human Services, September 2005.
2. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
3. Centers for Disease Control and Prevention. Sex Transm Dis Guidelines, 2006. MMWR 2006; 55:42-49.
4. Plummer FA, Chubb H, Simonsen JN, et al. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection. J Clin Invest 1993; 91:339-343.
5. Plummer FA, Chubb H, Simonsen JN, et al. Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis. J Clin Invest 1994; 93:1748-1755.
6. Hedges SR, Mayo MS, Mestecky J, et al. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect Immun 1999; 67:3937-3946.
7. Brooks GF, Lammel CJ. Humoral immune response to gonococcal infections. Clin Microbiol Rev 1989; 2:S5-10.
8. O'Reilly RJ, Lee L, Welch BG. Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. J Infect Dis 1976; 133:113-125.
9. McMillan A, McNeillage G, Young H, et al. Secretory antibody response of the cervix to infection with Neisseria gonorrhoeae. Br J Vener Dis 1979; 55:265-270.
10. McMillan A, McNeillage G, Young H. Antibodies to Neisseria gonorrhoeae: A study of the urethral exudates of 232 men. J Infect Dis 1979; 140:89-95.
11. Naumann M, Wessler S, Bartsch C, et al. Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor kappaB and activator protein 1 and the induction of inflammatory cytokines. J Exp Med 1997; 196:247-258.
12. Ramsey KH, Schneider H, Cross AS, et al. Inflammatory cytokines produced in response to experimental human gonorrhea. J Infect Dis 1995; 172:186-191.
13. Harvey HA, Post DM, Apicella MA. Immortalization of human urethral epithelial cells: A model for the study of the pathogenesis of and the inflammatory cytokine response to Neisseria gonorrhoeae infection. Infect Immun 2002; 70:5808-5815.
14. Anzala AO, Simonsen JN, Kimani J, et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 2000; 182:459-466.
15. Hedges SR, Sibley DA, Mayo MS, et al. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: Effects of concomitant infections. J Infect Dis 1998; 178:742-751.
16. Ness RB, Brunham RC, Shen C, et al. PID Evaluation Clinical Health (PEACH) Study Investigators. Associations among human leukocyte antigen (HLA) class II DQ variants, bacterial sexually transmitted diseases, endometritis, and fertility among women with clinical pelvic inflammatory disease. Sex Transm Dis 2004; 31:301-304.
17. Geisler WM, Tang J, Wang C, et al. Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. J Infect Dis 2004; 190:1723-1729.
18. Wang C, Tang J, Geisler WM, et al. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infections in high-risk adolescents. J Infect Dis 2005; 191: 1084-1092.
19. Wilson CM, Houser J, Partlow C, et al. The REACH (Reaching for Excellence in Adolescent Care and Health) project: Study design, methods, and population profile. J Adolesc Health 2001; 29:8-18.
20. Tang J, Wilson CM, Meleth S, et al. Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS 2002; 16:2275-2284.
21. Wang C, Song W, Lobashevsky E, et al. Cytokine and chemokine gene polymorphisms among ethnically diverse North Americans with HIV-1 infection. J Acquir Immune Defic Syndr 2004; 35:446-454.
22. Deleted in proof.
23. Tang J, Naik E, Costello C, et al. Characteristics of HLA class I and class II polymorphisms in Rwandan women. Exp Clin Immunogenet 2000; 17:185-198.
24. Yunis EJ, Larsen CE, Fernandez-Vina M, et al. Inheritable variable sizes of DNA stretches in the human MHC: Conserved extended haplotypes and their fragments or blocks. Tissue Antigens 2003; 62:1-20.
25. Just JJ, King MC, Thomson G, et al. African-American HLA class II allele and haplotype diversity (corrected and republished article originally printed in Tissue Antigens 1996, Dec; 48(6):636-644). Tissue Antigens 1997; 49:547-555.
26. Cao K, Hollenbach J, Shi X, et al. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001; 62:1009-1030.
27. Klitz W, Maiers M, Spellman S, et al. New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample ofEuropean Americans. Tissue Antigens 2003; 62:296-307.
28. Louie LG, Wallenstein E, Schmelzer K, et al. Report of the anthropology group from the Cytokine Polymorphism Component. In: Hansen J, Dupont B, eds. HLA 2004: Immunobiology of the Human MHC. Proceedings of 13th International Histocompatibility Workshop and Congress. Vol. 2. Seattle: IHWG Press, 2004.
29. Wang C, Tang J, Song W, et al. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004; 39:978-988.
30. Morahan G, Boutlis CS, Huang D, et al. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun 2002; 3:414-418.
31. Crowley-Nowick PA, Bell MC, Brockwell R, et al. Rectal immunization for induction of specific antibody in the genital tract of women. J Clin Immunol 1997; 17:370-379.
32. Rohan LC, Edwards RP, Kelly LA, et al. Optimization of the weck-Cel collection method for quantitation of cytokines in mucosal secretions. Clin Diagn Lab Immunol 2000; 7:45-48.
33. Hildesheim A, McShane LM, Schiffman M, et al. Cytokine and immunoglobulin concentrations in cervical secretions: Reproducibility of the Weck-cel collection instrument and correlates of immune measures. J Immunol Methods 1999; 225:131-143.
34. Crowley-Nowick PA, Ellenberg JH, Vermund SH, et al. Cytokine profile in genital tract secretions from female adolescents: Impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 2000; 181:939-945.
35. Wang C, Tang J, Crowley-Nowick PA, et al. Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents. Clin Exp Immunol 2005; 142:548-554.
36. Shrier LA, Bowman FP, Lin M, et al. Mucosal immunity of the adolescent female genital tract. J Adolesc Health 2003; 32:183-186.
37. Hoffmann SC, Stanley EM, Cox ED, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes. Transplantation 2001; 72:1444-1450.
38. Smith KA. Interleukin-2: Inception, impact, and implications. Science 1988; 240:1169-1176.
39. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci 1997; 2:d12-d26.
40. Deleted in proof.
41. Deleted in proof.
42. Deleted in proof.